Big Pharma Giants Including Pfizer and GSK Kickoff a New Year with Price Hikes
Outpacing Inflation on Hundreds of Brand Name Products





 



CSRxP: BIG PHARMA RINGS IN 2026 WITH MORE THAN 300 PRICE INCREASES ON BRAND
NAME DRUGS, OUTPACING START OF 2025

Big Pharma Giants Including Pfizer and GSK Kickoff a New Year with Price Hikes
Outpacing Inflation on Hundreds of Brand Name Products



Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a
statement Monday after brand name pharmaceutical companiesincreased prices
<[link removed]>
on hundreds of brand name prescription drugs to start the new year.



“Big Pharma is ringing in the new year with egregious price increases
outpacing the rate of inflation on hundreds of brand name prescription drugs,”
said CSRxP executive director Lauren Aronson. “Big Pharma’s price increases to
kickoff 2026 already surpass its pace at this same time last year,
demonstrating brand name drug companies are not slowing down in their
business-as-usual approach to price-gouging the American people.”



“Big Pharma’s repeated price hikes on brand name drugs, enabled by
anti-competitive tactics like gaming the U.S. patent system, are the root cause
of high drug prices in America and a major contributor to health care
inflation,” Aronson continued. “CSRxP looks forward to continuing to work with
members of Congress on both sides of the aisle, as well as the administration,
to lower prescription drug prices for the American people in 2026 by holding
Big Pharma accountable.”



According to Reuters
<[link removed]>
, Big Pharma planned to increase prices on at least 350 brand name drugs to
start the year, “including vaccines against COVID, RSV and shingles and
blockbuster cancer treatment Ibrance.”



According to Reuters “[t]he number of price increases for 2026 is up from the
same point last year.” The median price increase is four percent, outpacing the
most recent2.7 percent
<[link removed]> rate of inflation
from the U.S. Bureau of Labor Statistics.



“More price hikes and cuts can be expected in early January, which is
historically the biggest month for drugmakers to raise prices,” according to
Reuters.



Big Pharma giant Pfizer announced the most price increases so far “on around
80 different drugs including cancer drug Ibrance, migraine pill Nurtec, and
COVID treatment Paxlovid.” Brand name drug maker GSK is also expected to
increase prices “on around 20 drugs and vaccines,” with price increases ranging
from two percent to 8.9 percent.



Big Pharma’s price hikes have been repeatedly proven unjustified by any
improved clinical value for American patients. According to a December 2024
analysis
<[link removed]>from
the Institute of Clinical and Economical Review (ICER), brand name drug makers’
egregious price hikes on just five widely used prescription medications,
without any accompanying true innovation, cost U.S. patients and the health
care system an additional $815 million in 2023.



Read more on Big Pharma’s egregious pricing practices from last year HERE
<[link removed]>
.



Read more on the cost of Big Pharma’s unjustified price hikes HERE
<[link removed]>
.



Read more on bipartisan, market-based solutions to hold Big Pharma accountable
HERE <[link removed]>.



And stay tuned as we continue to monitor Big Pharma’s price increase in the
first weeks of the new year.



###

































Copyright © 2019 Campaign for Sustainable Rx Pricing
Our address is 1341 G St NW, #1100, Washington, DC xxxxxx


This email was sent to [email protected]. To unsubscribe please click
here.
<[link removed]>